Botulinum Toxin for Tinnitus: Masseter Muscle Review

🟢
Peer-Reviewed Research

A scoping review of 284 scientific records found only four studies that directly examined the link between masseter muscle activity and tinnitus, highlighting a significant gap in clinical evidence for targeted treatments. Authors Jacopo Gardellin, Marta D’Angelo, and Lorenzo Spadotto argue that while botulinum toxin type A (BoNT/A) injections into jaw muscles present a plausible, hypothesis-based therapy for a specific form of tinnitus, its use remains experimental and urgently requires validation in controlled trials.

Key Takeaways

  • Growing evidence supports a “somatosensory” tinnitus subtype influenced by muscles and joints in the head, neck, and jaw.
  • A rigorous review identified minimal direct clinical research connecting masseter muscle hyperactivity to tinnitus perception.
  • Botulinum toxin (BoNT/A) can relax overactive jaw muscles, providing a strong theoretical basis for reducing abnormal sensory signals that may drive tinnitus.
  • Current evidence for BoNT/A improving tinnitus is insufficient; any treatment should be considered experimental and part of a multidisciplinary plan.
  • Prospective, controlled clinical trials are the essential next step to determine if this muscle-focused approach is effective.

The Anatomical Link Between Jaw Muscles and Ear Perception

The concept of somatosensory tinnitus proposes that structures outside the auditory system—like muscles, tendons, and joints in the head, neck,

💊 Related Supplements
Evidence-based options: zinc picolinate, magnesium glycinate

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. The research summaries presented here are based on published studies and should not be used as a substitute for professional medical consultation. Always consult a qualified healthcare provider before making any changes to your health regimen.

⚡ Research Insider Weekly

Peer-reviewed health research, simplified. Early access findings, clinical trial alerts & regulatory news — delivered weekly.

No spam. Unsubscribe anytime. Powered by Beehiiv.

Similar Posts